Related Experiment Video

Updated: Aug 10, 2026

Expression, Detergent Solubilization, and Purification of a Membrane Transporter, the MexB Multidrug Resistance Protein
10:43

Expression, Detergent Solubilization, and Purification of a Membrane Transporter, the MexB Multidrug Resistance Protein

Published on: December 3, 2010

Multidrug resistance

R L Fine

    Cancer Chemotherapy and Biological Response Modifiers
    |January 1, 1988
    PubMed

    Insights

    Recent advances in understanding multidrug resistance (MDR) mechanisms offer new therapeutic strategies. However, the clinical relevance of in-vitro MDR and co-existing resistance in tumors remains uncertain.

    Area of Science:

    • Oncology
    • Pharmacology
    • Molecular Biology

    Background:

    • Multidrug resistance (MDR) is a significant challenge in cancer therapy.
    • Recent scientific advancements have rapidly improved the understanding of MDR mechanisms.

    Purpose of the Study:

    • To review the recent progress in understanding multidrug resistance.
    • To discuss the potential clinical applications of new findings in MDR therapies.

    Main Methods:

    • Literature review of recent studies on multidrug resistance mechanisms.
    • Analysis of new inhibitors, screening techniques, and therapeutic strategies for MDR.
    • Discussion of the translation of in-vitro findings to clinical practice.

    Main Results:

    • Significant progress has been made in elucidating MDR mechanisms.
    • New MDR inhibitors and equitoxic agents are emerging.
    • Advanced screening techniques and therapeutic applications are being developed.

    Conclusions:

    • Clinical oncologists may soon have access to novel MDR-targeting agents and therapies.
    • A critical question remains whether in-vitro MDR accurately reflects clinical resistance.
    • Other resistance mechanisms may coexist with MDR in patient tumors, complicating treatment.

    More Related Videos

    Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray07:35

    Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

    Published on: April 25, 2014

    Characterizing Multidrug Efflux Systems in Acinetobacter baumannii Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System05:06

    Characterizing Multidrug Efflux Systems in Acinetobacter baumannii Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System

    Published on: January 5, 2024

    Related Concept Videos

    Mismatch Repair01:36

    Mismatch Repair

    Overview
    Antibiotic Selection00:57

    Antibiotic Selection

    Overview
    Treatment Resistant Cancers02:56

    Treatment Resistant Cancers

    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
    Development of Antibiotic Resistance01:30

    Development of Antibiotic Resistance

    Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
    Mechanism of Antibiotic Resistance in MRSA01:25

    Mechanism of Antibiotic Resistance in MRSA

    Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
    Clinical Significance of Antibiotic Resistance01:25

    Clinical Significance of Antibiotic Resistance

    Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...